Transplantation in the HIV+ Patient
Article first published online: 17 SEP 2008
American Journal of Transplantation
Volume 1, Issue 1, pages 13–17, May 2001
How to Cite
Kuo, P. C. and Stock, P. G. (2001), Transplantation in the HIV+ Patient. American Journal of Transplantation, 1: 13–17. doi: 10.1034/j.1600-6143.2001.010104.x
- Issue published online: 17 SEP 2008
- Article first published online: 17 SEP 2008
- Received 8 September 2000, revised and accepted for publication 8 December 2000
- A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infections and CD4 counts of 200/mm or less. N Engl J Med 1997; 337: 725–733. & .
- Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853–860. , , et al.
- Effect of gender, age, transmission category and ARV therapy on the progression of human immunodeficiency virus infection using multistate marker models. Epidemiology 1998; 9: 605–612. , , .
- Effectiveness of potent ARV therapy on time to AIDS and death in men with known HIV infection duration. JAMA 1998; 280: 1497–1503. , , .
- Survival from early, intermediate and late stages of HIV infection. JAMA 1996; 275: 1329–1334. , , .
- Human immunodeficiency virus infection in patients with solid organ transplants: report of five cases and review. Rev Inf Dis 1991; 13: 537–547. , , , , .
- Transplantation in HIV+ patients. Transplantation 1990; 49: 354–358. , , , , , .
- The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation. Transplantation 1993; 55: 95–103. , , et al.
- Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55 Gag: mechanism for antiviral effects of cyclosporin A. Virology 1998; 245: 197–202. , , , .
- Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels. J Virol 1998; 72: 6430–6436. , , .
- Epidemiology of human immunodeficiency virus associated opportunisitic infections in the United States in the era of highly active antiretroviral therapy. Clin Inf Dis 2000; 30: S5–S14. , , et al.
- Enhancement of hepatitis C virus replication and liver damage in HIV coinfected patients on retroviral combination therapy. AIDS 1998; 12: 116–117. , , , , , .
- HIV-associated nephropathy. Kidney Int 1999; 56: 1161–1176. .
- Patients with HIV infection and end stage renal disease. Adv Renal Replace Ther 1996; 3: 287–292. & .
- Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Inf Dis 2000; 30: S77–S84. , , , .
- The natural history of hepatitis C virus infection in multitransfused hemophiliacs: effects of coinfection with human immunodeficiency virus. J AIDS 1993; 6: 602–607. & .
- Hepatitis C virus and organ transplantation. Transplantation 1996; 62: 147–154. , , , .
- Protease inhibitors in patients with HIV disease: clinically important pharmacokinetic considerations. Clin Pharmacokinet 1997; 32: 139–143. , , .
- HIV protease inhibitors. N Engl J Med 1998; 338: 1281–1292. .